As the global population ages, the demand for endocrine support to improve quality of life, especially in sexual health, is growing. Erectile dysfunction (ED) is a common condition that affects a significant percentage of aging men, characterized by the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. While occasional difficulty with erections is normal, persistent ED can indicate underlying health concerns that require medical attention.

​

Popular treatments, like Viagra and Cialis, have prove to be effective in treatment in erectile dyfunction patients. However, through prolonged dosing patients reported both heaches and flushing of the skin. Additionally, higher dosing was required to achieve a substantial effect in performance through extended use of these drugs.  We are developing a combination therapy that merges the benefits of Viagra with a sexual desire modulator to restore men's sexual function as they age.

​

The use of CR-067 tablets aim to decrease the effective dosage for the treatment of erectile dysfunction while also minimizing the potential of side effects caused with current drugs on the market that treat ED.  

​